biolongevity labs bpc-157 and the Recovery-First Peptide Strategy BPC-157 - Research Labs

How AOD-9604 Works (in Brief) AOD-9604 was engineered from the C-terminal segment of human growth hormone (amino acids 177191) the portion thought to influence fat metabolism. In preclinical models, this fragment supported fat oxidation and lipid mobilization without the broader hormonal effects of full-length hGH. Because it does not activate the traditional hGH receptor, its fat-metabolism effects are considered indirect and receptor-independent. Discovery & Research Milestones Originally developed in the 1990s as a potential anti-obesity drug

Listen to Petas response in the video

The full sequence, with dates, is laid out on our FDA peptide compounding status page

Discuss these potential mild effects so patients know they are normal